Dec 19, 2025
FDA Puts Cassava’s Simufilam Epilepsy Trial On Full Clinical Hold

Cassava Sciences Inc. (NASDAQ:SAVA) received a formal letter from the U.S. Food and Drug Administration (FDA) related to the company’s trial for simufilam Following previously reported communications with the FDA regarding Cassava’s investigational new drug application and proposed proof-of-concept clinical…

Dec 19, 2025
CarMax Bets On Lower Prices To Jumpstart Sales After 47% Profit Drop

CarMax Inc. (NYSE:KMX) reported its fiscal third-quarter results on Thursday, broadly in line with its guidance range. Here are the key analyst takeaways: Stephens analyst Jeff Lick maintained an Equal-Weight rating, while reducing the price target from $39 to $36. RBC Capital Markets…

Dec 19, 2025
Birkenstock Posts Q4 Beat, Offset By Ongoing FX, Tariff Pressures

While Birkenstock Holding PLC (NYSE:BIRK) reported better-than-expected fourth-quarter results, this was overshadowed by the ongoing forex and tariff pressures, according to Guggenheim Securities. • Birkenstock Holding shares are under pressure. What’s pulling BIRK shares down? The Birkenstock Holding Analyst: Analyst…

Dec 19, 2025
What’s Going On With CoreWeave Stock Friday?

CoreWeave, Inc. (NASDAQ:CRWV) shares are trading higher Thursday after the company announced it joined the Department of Energy’s Genesis Mission. CoreWeave stock is showing exceptional strength. What’s behind CRWV gains? What To Know: The Genesis Mission is a Department of…

Dec 19, 2025
What’s Going On With Oracle Stock Today?

Shares of Oracle Corporation (NASDAQ:ORCL) are trading higher Friday after reports confirmed the technology company will be one of TikTok’s new owners. What To Know: TikTok’s fate in the United States has been uncertain due to U.S. President Donald Trump‘s…

Dec 19, 2025
What’s Going On With Safe & Green Holdings Stock?

Shares of Safe & Green Holdings Corp. (NASDAQ:SGBX) are on watch Friday after the construction engineering company acquired Giant Holdings. Safe & Green Holdings stock is showing downward pressure. What’s ahead for SGBX stock? What To Know: Safe & Green…

Dec 19, 2025
BioMarin Boosts Rare Disease Portfolio With Amicus Buyout, Stocks Rally

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and Amicus Therapeutics, Inc. (NASDAQ:FOLD) shares are trading higher on Friday after the companies penned a merger deal. Today, BioMarin agreed to acquire Amicus Therapeutics for a total equity value of about $4.8 billion. • BioMarin…